Bessemer Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,538
| Closed | -$93K | – | 2043 |
|
|
2022
Q2 | $93K | Hold |
1,538
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q1 | $97K | Hold |
1,538
| – | – | ﹤0.01% | 975 |
|
|
2021
Q4 | $117K | Hold |
1,538
| – | – | ﹤0.01% | 965 |
|
|
2021
Q3 | $172K | Hold |
1,538
| – | – | ﹤0.01% | 819 |
|
|
2021
Q2 | $249K | Hold |
1,538
| – | – | ﹤0.01% | 744 |
|
|
2021
Q1 | $187K | Hold |
1,538
| – | – | ﹤0.01% | 764 |
|
|
2020
Q4 | $235K | Buy |
+1,538
| New | +$235K | ﹤0.01% | 710 |
|
|
2020
Q3 | – | Sell |
-180
| Closed | -$13K | – | 1413 |
|
|
2020
Q2 | $13K | Buy |
+180
| New | +$13K | ﹤0.01% | 1501 |
|